<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">29553335</PMID>
      <DateCompleted>
        <Year>2019</Year>
        <Month>02</Month>
        <Day>11</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>04</Month>
        <Day>08</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">1080-6059</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>24</Volume>
            <Issue>4</Issue>
            <PubDate>
              <Year>2018</Year>
              <Month>Apr</Month>
            </PubDate>
          </JournalIssue>
          <Title>Emerging infectious diseases</Title>
          <ISOAbbreviation>Emerg Infect Dis</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Cooperative Recognition of Internationally Disseminated Ceftriaxone-Resistant Neisseria gonorrhoeae Strain.</ArticleTitle>
        <Pagination>
          <StartPage>735</StartPage>
          <EndPage>740</EndPage>
          <MedlinePgn>735-40</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.3201/eid2404.171873</ELocationID>
        <Abstract>
          <AbstractText>Ceftriaxone remains a first-line treatment for patients infected by Neisseria gonorrhoeae in most settings. We investigated the possible spread of a ceftriaxone-resistant FC428 N. gonorrhoeae clone in Japan after recent isolation of similar strains in Denmark (GK124) and Canada (47707). We report 2 instances of the FC428 clone in Australia in heterosexual men traveling from Asia. Our bioinformatic analyses included core single-nucleotide variation phylogeny and in silico molecular typing; phylogenetic analysis showed close genetic relatedness among all 5 isolates. Results showed multilocus sequence type 1903; N. gonorrhoeae sequence typing for antimicrobial resistance (NG-STAR) 233; and harboring of mosaic penA allele encoding alterations A311V and T483S (penA-60.001), associated with ceftriaxone resistance. Our results provide further evidence of international transmission of ceftriaxone-resistant N. gonorrhoeae. We recommend increasing awareness of international spread of this drug-resistant strain, strengthening surveillance to include identifying treatment failures and contacts, and strengthening international sharing of data.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Lahra</LastName>
            <ForeName>Monica M</ForeName>
            <Initials>MM</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Martin</LastName>
            <ForeName>Irene</ForeName>
            <Initials>I</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Demczuk</LastName>
            <ForeName>Walter</ForeName>
            <Initials>W</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Jennison</LastName>
            <ForeName>Amy V</ForeName>
            <Initials>AV</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Lee</LastName>
            <ForeName>Ken-Ichi</ForeName>
            <Initials>KI</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Nakayama</LastName>
            <ForeName>Shu-Ichi</ForeName>
            <Initials>SI</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Lefebvre</LastName>
            <ForeName>Brigitte</ForeName>
            <Initials>B</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Longtin</LastName>
            <ForeName>Jean</ForeName>
            <Initials>J</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ward</LastName>
            <ForeName>Alison</ForeName>
            <Initials>A</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Mulvey</LastName>
            <ForeName>Michael R</ForeName>
            <Initials>MR</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wi</LastName>
            <ForeName>Teodora</ForeName>
            <Initials>T</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ohnishi</LastName>
            <ForeName>Makoto</ForeName>
            <Initials>M</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Whiley</LastName>
            <ForeName>David</ForeName>
            <Initials>D</Initials>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Emerg Infect Dis</MedlineTA>
        <NlmUniqueID>9508155</NlmUniqueID>
        <ISSNLinking>1080-6040</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D065093">beta-Lactamase Inhibitors</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>75J73V1629</RegistryNumber>
          <NameOfSubstance UI="D002443">Ceftriaxone</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D002443" MajorTopicYN="N">Ceftriaxone</DescriptorName>
          <QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D016680" MajorTopicYN="N">Genome, Bacterial</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D023281" MajorTopicYN="N">Genomics</DescriptorName>
          <QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006069" MajorTopicYN="N">Gonorrhea</DescriptorName>
          <QualifierName UI="Q000382" MajorTopicYN="Y">microbiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008826" MajorTopicYN="N">Microbial Sensitivity Tests</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009344" MajorTopicYN="N">Neisseria gonorrhoeae</DescriptorName>
          <QualifierName UI="Q000145" MajorTopicYN="N">classification</QualifierName>
          <QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010802" MajorTopicYN="N">Phylogeny</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D020641" MajorTopicYN="N">Polymorphism, Single Nucleotide</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D018440" MajorTopicYN="Y">beta-Lactam Resistance</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D065093" MajorTopicYN="N">beta-Lactamase Inhibitors</DescriptorName>
          <QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="Y">Australia</Keyword>
        <Keyword MajorTopicYN="Y">Canada</Keyword>
        <Keyword MajorTopicYN="Y">China</Keyword>
        <Keyword MajorTopicYN="Y">France</Keyword>
        <Keyword MajorTopicYN="Y">Japan</Keyword>
        <Keyword MajorTopicYN="Y">Neisseria gonorrhoeae</Keyword>
        <Keyword MajorTopicYN="Y">Spain</Keyword>
        <Keyword MajorTopicYN="Y">antimicrobial resistance</Keyword>
        <Keyword MajorTopicYN="Y">azithromycin</Keyword>
        <Keyword MajorTopicYN="Y">cefixime</Keyword>
        <Keyword MajorTopicYN="Y">ceftriaxone</Keyword>
        <Keyword MajorTopicYN="Y">cephalosporin</Keyword>
        <Keyword MajorTopicYN="Y">ciprofloxacin</Keyword>
        <Keyword MajorTopicYN="Y">gentamycin</Keyword>
        <Keyword MajorTopicYN="Y">gonorrhea</Keyword>
        <Keyword MajorTopicYN="Y">penA gene</Keyword>
        <Keyword MajorTopicYN="Y">penicillin</Keyword>
        <Keyword MajorTopicYN="Y">penicillinase</Keyword>
        <Keyword MajorTopicYN="Y">spectinomycin</Keyword>
        <Keyword MajorTopicYN="Y">tetracycline</Keyword>
        <Keyword MajorTopicYN="Y">β-lactam</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>3</Month>
          <Day>20</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>3</Month>
          <Day>20</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2019</Year>
          <Month>2</Month>
          <Day>12</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">29553335</ArticleId>
        <ArticleId IdType="pmc">PMC5875269</ArticleId>
        <ArticleId IdType="doi">10.3201/eid2404.171873</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Ohnishi M, Saika T, Hoshina S, Iwasaku K, Nakayama S, Watanabe H, et al.
Ceftriaxone-resistant Neisseria gonorrhoeae, Japan.
Emerg Infect Dis. 2011;17:148–9. 10.3201/eid1701.100397</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3201/eid1701.100397</ArticleId>
            <ArticleId IdType="pmc">PMC3204624</ArticleId>
            <ArticleId IdType="pubmed">21192886</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ohnishi M, Golparian D, Shimuta K, Saika T, Hoshina S, Iwasaku K, et al.
Is Neisseria gonorrhoeae initiating a future era of untreatable gonorrhea?: detailed characterization of the first strain with high-level resistance to ceftriaxone.
Antimicrob Agents Chemother. 2011;55:3538–45. 10.1128/AAC.00325-11</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/AAC.00325-11</ArticleId>
            <ArticleId IdType="pmc">PMC3122416</ArticleId>
            <ArticleId IdType="pubmed">21576437</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Unemo M, Golparian D, Nicholas R, Ohnishi M, Gallay A, Sednaoui P. High-level cefixime- and ceftriaxone-resistant Neisseria gonorrhoeae in France: novel penA mosaic allele in a successful international clone causes treatment failure.
Antimicrob Agents Chemother. 2012;56:1273–80. 10.1128/AAC.05760-11</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/AAC.05760-11</ArticleId>
            <ArticleId IdType="pmc">PMC3294892</ArticleId>
            <ArticleId IdType="pubmed">22155830</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cámara J, Serra J, Ayats J, Bastida T, Carnicer-Pont D, Andreu A, et al.
Molecular characterization of two high-level ceftriaxone-resistant Neisseria gonorrhoeae isolates detected in Catalonia, Spain.
J Antimicrob Chemother. 2012;67:1858–60. 10.1093/jac/dks162</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/jac/dks162</ArticleId>
            <ArticleId IdType="pubmed">22566592</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lahra MM, Ryder N, Whiley DM. A new multidrug-resistant strain of Neisseria gonorrhoeae in Australia.
N Engl J Med. 2014;371:1850–1. 10.1056/NEJMc1408109</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1056/NEJMc1408109</ArticleId>
            <ArticleId IdType="pubmed">25372111</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Deguchi T, Yasuda M, Hatazaki K, Kameyama K, Horie K, Kato T, et al.
New clinical strain of Neisseria gonorrhoeae with decreased susceptibility to ceftriaxone, Japan.
Emerg Infect Dis. 2016;22:142–4. 10.3201/eid2201.150868</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3201/eid2201.150868</ArticleId>
            <ArticleId IdType="pmc">PMC4696695</ArticleId>
            <ArticleId IdType="pubmed">26689442</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nakayama S, Shimuta K, Furubayashi K, Kawahata T, Unemo M, Ohnishi M. New ceftriaxone- and multidrug-resistant Neisseria gonorrhoeae strain with a novel mosaic penA gene isolated in Japan.
Antimicrob Agents Chemother. 2016;60:4339–41. 10.1128/AAC.00504-16</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/AAC.00504-16</ArticleId>
            <ArticleId IdType="pmc">PMC4914677</ArticleId>
            <ArticleId IdType="pubmed">27067334</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lefebvre B, Martin I, Demczuk W, Deshaies L, Michaud S, Labbé AC, et al.
Ceftriaxone-Resistant Neisseria gonorrhoeae, Canada, 2017.
Emerg Infect Dis. 2018;24:381–3. 10.3201/eid2402.171756</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3201/eid2402.171756</ArticleId>
            <ArticleId IdType="pmc">PMC5782888</ArticleId>
            <ArticleId IdType="pubmed">29131780</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Terkelsen D, Tolstrup J, Hundahl Johnsen C, Lund O, Kiellberg Larsen H, Worning P, et al.
Multidrug-resistant Neisseria gonorrhoeae infection with ceftriaxone resistance and intermediate resistance to azithromycin, Denmark, 2017.
Euro Surveill. 2017;22:42. 10.2807/1560-7917.ES.2017.22.42.17-00659</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2807/1560-7917.ES.2017.22.42.17-00659</ArticleId>
            <ArticleId IdType="pmc">PMC5710115</ArticleId>
            <ArticleId IdType="pubmed">29067905</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Unemo M, Golparian D, Sánchez-Busó L, Grad Y, Jacobsson S, Ohnishi M, et al.
The novel 2016 WHO Neisseria gonorrhoeae reference strains for global quality assurance of laboratory investigations: phenotypic, genetic and reference genome characterization.
J Antimicrob Chemother. 2016;71:3096–108. 10.1093/jac/dkw288</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/jac/dkw288</ArticleId>
            <ArticleId IdType="pmc">PMC5079299</ArticleId>
            <ArticleId IdType="pubmed">27432602</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Clinical and Laboratory Standards Institute. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard, 10th edition (M07–A10). Wayne (PA): The Institute; 2015.</Citation>
        </Reference>
        <Reference>
          <Citation>Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing: twenty-seventh informational supplement (M100–S27). Wayne (PA): The Institute; 2017.</Citation>
        </Reference>
        <Reference>
          <Citation>European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for the interpretation of MICs and zone diameters. 2017.  [cited 2017 Oct 12]. http://www.eucast.org/clinical_breakpoints/</Citation>
        </Reference>
        <Reference>
          <Citation>Demczuk W, Lynch T, Martin I, Van Domselaar G, Graham M, Bharat A, et al.
Whole-genome phylogenomic heterogeneity of Neisseria gonorrhoeae isolates with decreased cephalosporin susceptibility collected in Canada between 1989 and 2013.
J Clin Microbiol. 2015;53:191–200. 10.1128/JCM.02589-14</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/JCM.02589-14</ArticleId>
            <ArticleId IdType="pmc">PMC4290921</ArticleId>
            <ArticleId IdType="pubmed">25378573</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bankevich A, Nurk S, Antipov D, Gurevich AA, Dvorkin M, Kulikov AS, et al.
SPAdes: a new genome assembly algorithm and its applications to single-cell sequencing.
J Comput Biol. 2012;19:455–77. 10.1089/cmb.2012.0021</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1089/cmb.2012.0021</ArticleId>
            <ArticleId IdType="pmc">PMC3342519</ArticleId>
            <ArticleId IdType="pubmed">22506599</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Seemann T. Prokka: rapid prokaryotic genome annotation.
Bioinformatics. 2014;30:2068–9. 10.1093/bioinformatics/btu153</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/bioinformatics/btu153</ArticleId>
            <ArticleId IdType="pubmed">24642063</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Petkau A, Mabon P, Sieffert C, Knox NC, Cabral J, Iskander M, et al.
SNVPhyl: a single nucleotide variant phylogenomics pipeline for microbial genomic epidemiology.
Microb Genom. 2017;3:e000116.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5628696</ArticleId>
            <ArticleId IdType="pubmed">29026651</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Martin IMC, Ison CA, Aanensen DM, Fenton KA, Spratt BG. Rapid sequence-based identification of gonococcal transmission clusters in a large metropolitan area.
J Infect Dis. 2004;189:1497–505. 10.1086/383047</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1086/383047</ArticleId>
            <ArticleId IdType="pubmed">15073688</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jolley KA, Maiden MCJ. BIGSdb: Scalable analysis of bacterial genome variation at the population level.
BMC Bioinformatics. 2010;11:595. 10.1186/1471-2105-11-595</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/1471-2105-11-595</ArticleId>
            <ArticleId IdType="pmc">PMC3004885</ArticleId>
            <ArticleId IdType="pubmed">21143983</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Demczuk W, Sidhu S, Unemo M, Whiley DM, Allen VG, Dillon JR, et al.
Neisseria gonorrhoeae sequence typing for antimicrobial resistance, a novel antimicrobial resistance multilocus typing scheme for tracking global dissemination of N. gonorrhoeae strains.
J Clin Microbiol. 2017;55:1454–68. 10.1128/JCM.00100-17</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/JCM.00100-17</ArticleId>
            <ArticleId IdType="pmc">PMC5405263</ArticleId>
            <ArticleId IdType="pubmed">28228492</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>World Health Organization. Report on global sexually transmitted infection surveillance 2015 Geneva: The Organization. 2016.  [cited 16 Jan 2018]. http://apps.who.int/iris/bitstream/10665/249553/1/9789241565301-eng.pdf?ua=1</Citation>
        </Reference>
        <Reference>
          <Citation>Newman L, Rowley J, Vander Hoorn S, Wijesooriya NS, Unemo M, Low N, et al.
Global estimates of the prevalence and incidence of four curable sexually transmitted infections in 2012 based on systematic review and global reporting.
PLoS One. 2015;10:e0143304. 10.1371/journal.pone.0143304</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0143304</ArticleId>
            <ArticleId IdType="pmc">PMC4672879</ArticleId>
            <ArticleId IdType="pubmed">26646541</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chisholm SA, Mouton JW, Lewis DA, Nichols T, Ison CA, Livermore DM. Cephalosporin MIC creep among gonococci: time for a pharmacodynamic rethink?
J Antimicrob Chemother. 2010;65:2141–8. 10.1093/jac/dkq289</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/jac/dkq289</ArticleId>
            <ArticleId IdType="pubmed">20693173</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Martin I, Sawatzky P, Liu G, Allen V, Lefebvre B, Hoang L, et al.
Decline in decreased cephalosporin susceptibility and increase in azithromycin resistance in Neisseria gonorrhoeae, Canada.
Emerg Infect Dis. 2016;22:65–7. 10.3201/eid2201.151247</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3201/eid2201.151247</ArticleId>
            <ArticleId IdType="pmc">PMC4696705</ArticleId>
            <ArticleId IdType="pubmed">26689114</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wi T, Lahra MM, Ndowa F, Bala M, Dillon JR, Ramon-Pardo P, et al.
Antimicrobial resistance in Neisseria gonorrhoeae: Global surveillance and a call for international collaborative action.
PLoS Med. 2017;14:e1002344. 10.1371/journal.pmed.1002344</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pmed.1002344</ArticleId>
            <ArticleId IdType="pmc">PMC5501266</ArticleId>
            <ArticleId IdType="pubmed">28686231</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
